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Abstract
Background: Japanese encephalitis (JE) is one of the leading causes of acute encephalopathy with the highest
mortality rate of 30-50%. The purpose of this study was to understand complex biological processes of host
response during the progression of the disease. Virus was subcutaneously administered in mice and brain was
used for whole genome expression profiling by cDNA microarray.
Results: The comparison between viral replication efficiency and disease progression confirms the active role of
host response in immunopathology and disease severity. The histopathological analysis confirms the severe
damage in the brain in a time dependent manner. Interestingly, the transcription profile reveals significant and
differential expression of various pattern recognition receptors, chemotactic genes and the activation of
inflammasome. The increased leukocyte infiltration and aggravated CNS inflammation may be the cause of disease
severity.
Conclusion: This is the first report that provides a detailed picture of the host transcriptional response in a natural
route of exposure and opens up new avenues for potential therapeutic and prophylactic strategies against
Japanese encephalitis virus.
Background
The host response to infection is central to the effective
control and ultimate clearance of invading pathogens or
removal of infected cells. Infection of host with a viral
pathogen marks the onset of changes in the host cell’s
microenvironment. Such changes in host gene expres-
sion could be a cellular antivirus response, a virus
induced response that facilitate its own replication and
spread or a non-specific response that neither promotes
nor prevents virus infection. This alteration of expres-
sion of many cellular genes can be identified using
cDNA microarray [1].
Defining the transcriptional regulation of host genes
on virus infection can be used as a tool to obtain an ela-
borate insight into mechanisms of host-virus interac-
tions and to unravel the molecular basis of disease
pathogenesis. Viruses from several families can infect
neurons in the CNS (Central Nervous System) and the
s t u d yo fg e n ee x p r e s s i o nc h a n g e si nt h eC N Sd u r i n g
virus infection can lead to identification of new genes
whose function is essential either for the promotion or
prevention of virus infection [2,3].
Japanese Encephalitis is one of the most dreaded mos-
quito borne encephalitis virus causing acute encephalitis
in humans. Among the medically important flaviviruses,
J E Vi n f e c t i o nh a st h eh i g h e s tm o r t a l i t yr a t eo f3 0 - 5 0 %
[4,5] and remains as a major public health problem in
several parts of Asia. The main concern is the constant
spreading of JE to new geographical areas [6]. Better
understanding of JEV pathogenesis is required to identify
risk factors for progression of disease and viral persis-
tence, which may help in the development of differential
diagnostics and new therapeutic interventions.
In a previous study, employing cDNA microarray, we
identified various antiviral genes along with the innate
immune response related chemokine expression at very
early phase of infection in mouse neuronal cells [7]. How-
ever, there is no information available on genome wide
host gene expression changes induced by JEV in the CNS
and in a natural route of infection. There is a requirement
to understand the molecular events responsible for disease
progression, viral persistence and complex biological pro-
cesses of host response during the complete course of JEV
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flammation, disease severity and death.
Thus, we employed cDNA microarray for the systema-
tic analysis of global host transcriptional responses in
CNS of JEV infected mice. In the recent epidemics, it
has been observed that the mortality rate in JEV infected
patients is higher in 1-5 years of age group with imma-
ture immune system. So we employed a young mice
model to explore the precise molecular events involved
in JEV infection of CNS during the disease severity.
Subcutaneous challenge of JEV in one-week-old mice
provides a natural route of exposure to study molecular
mechanism of JEV pathogenesis in CNS. In our earlier
report using this animal model we observed a significant
regulation of IFN-g in virus infected mice spleen, which
demonstrates a specific but insufficient anti-viral
response in the periphery to limit virus spread to brain
[8]. Thus this model with immature immune system
may provide important information about the role of
host response in disease severity. The reproducibility of
the infection and diseases symptoms was verified with a
significant number of experimental repetitions in newly
established animal model and there was no variation in
the disease symptoms of the individual animals at any
time point of infection and the mortality rate was also
100% at 6 DPI (Day post-infection).
It has already been reported that cerebral cortex is an
important site of virus replication, inflammation, injury
and is associated with encephalitis in the JEV-infected
host [9,10]. Thus we employed brain cerebral cortex for
the investigation of transcriptomic profile of host
r e s p o n s ei nJ E Vi n f e c t i o n .O u rr e s u l t st h u sp r o v i d ea
genome-wide investigation of an animal model of JEV
infection and a genomic view of systemic host-virus
interactions during infection.
Results
Evaluation of viral load and histopathological analysis in
mice CNS after subcutaneous infection with JEV
Animals showed JE specific symptoms with the progres-
sion in severity in a time dependent manner. After sub-
cutaneous inoculation, virus load in brain was evaluated
up to 6 DPI by plaque titration assay (Figure 1). JEV
replicates rapidly in brain with an increase in titre from
2 DPI and reached a maximal viral load at 5 DPI. Subse-
quently, the viral load remained constant until death at
6 DPI. Figure S1 (Additional file 1) is showing the histo-
pathological analysis of cerebral cortex from mock- and
JEV-infected animals with the pathological changes after
viral infection. The analysis showed congestion and dila-
tion of blood vessels at 1 DPI. A time dependent
increase in mononuclear cell infiltration, prominent
peri-vascular cuffing and neuronal degeneration was
observed in further time points of infection.
Host transcription profile after JEV infection
Using whole genome microarray the host transcription
profile was studied in mouse brain, the data from mock-
and JEV-infected animals were compared in time course
study after 1, 2, 4 and 5 DPI. Overall, the largest differ-
ence in transcription levels between the mock- and JEV-
infected groups was detected at 5 DPI, corresponding to
the time of maximum viral load in brain. A total 833
genes were up regulated and 479 genes were down regu-
lated at 5 DPI (Table 1). The hierarchical clustering also
showed significant regulation of a large set of genes at 5
DPI (Figure 2a and 2b). Gene expression profile at 1
DPI was compared with 5 DPI and 288 genes showed
similar regulation in their expression. However, the
more similarity in gene expression was observed when 1
DPI was compared with 4 DPI (Figure 3). The gene
modulation seems to correlate with viral replication and
classification of genes reveals critical role of inflamma-
tion and immune response in JEV infection (Table 2).
Expression profile of cell surface molecules in brain after
JEV infection
The host transcription profile in brain showed the effect
of JEV infection on expression of various cellular
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Figure 1 Viral load in mouse brain infected with JEV.V i r a ll o a d
in the cerebral cortex of mice infected with 10
3 PFU of JEV at
various days post-infection (DPI). Infectious virus titre was
determined using Plaque formation assay on porcine stable (PS)
kidney cells. Values are mean ± SE of four replicates each.
Table 1 Differentially expressed genes in mouse brain at
different days after JEV infection
Time
[Day post infection]
Up Down
Day 1 342 384
Day 2 381 259
Day 4 459 425
Day 5 833 479
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Page 2 of 13receptors. Gene ontology analysis of these significantly
activated cell surface receptors showed their involve-
ment in immune response, inflammatory response, cell
adhesion, defense response, proteolysis, endocytosis and
chemokine signaling (Table 3). The lectin receptors like
Clec7a, Clec5a, Clec4e involved in the immune
responses showed a high level of expression at 5 DPI
along with other receptors involved in immune response
like Masp2. Receptors involved in immune response like
Cd8a and Cd40 were significantly up-regulated at 5 DPI
only except Lgals3bp which has showed significant up
regulation at 1 DPI also. The receptor involved in
inflammatory response showed high level of expression
at 5 DPI like Tlr (Toll-like receptor) 2, Tlr7, Edg3,
Tnfrsf1b and Cd14 except sialic acid receptor Siglec1
and Tlr4 which showed significant regulation at 1 DPI
also (Table 3). The receptors of cell adhesion family like
Sell, Icam1, Amica1, Vcam1, Itgb2 and Itgam showed
high level of expression at 5 DPI. The receptors involved
in signal transduction like Gpr84 showed increase in
their expression in association with the disease progres-
sion. However, receptors like Osmr and Admr were sig-
nificantly up regulated at 5 DPI except Ccrl2 which was
up regulated at 2 DPI. The receptors involved in defense
response showed varying levels of expression, like Tlr1
was up regulated throughout the disease course with
increase in up regulation at 5 DPI while C180 showed a
gradual increase in regulation with significant up
   1 DPI         2 DPI        4 DPI         5 DPI     1 DPI         2 DPI          4 DPI         5 DPI 
(B) (A)
Figure 2 Global gene expression profiles in the brain of BALB/c mice in response to JEV infection. Genes were sorted using hierarchical
clustering, average linkage and Pearson uncentred correlation. Green and red bands represent downregulated or upregulated levels of mRNA
expression relative to mock-infected mouse, respectively. (A) Genes upregulated (≥2.0-fold changes) with P ≤ 0.05. (B) Genes downregulated (≤
-2.0-fold change) with P ≤ 0.05.
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Page 3 of 13regulation at 4 and 5 DPI. Another receptor Clec2 d,
involved in defense response was up regulated at 1 DPI
and further up regulation was found at 4 and 5 DPI.
Interestingly, Tlr3 showed up regulation at all the time
points of infection but there was an increase in level of
expression at 1 and 4 DPI. However, T cell mediated
cytotoxicity receptor Ptprc showed high level of expres-
sion at 4 and 5 DPI. Interestingly, receptors involved in
cytokine and chemokine signalling like Csf2rb2, Csf2rb1,
Ccr5 and Il2rb showed significant up regulation only at
5 DPI except Lilrb3 which was significantly up regulated
at 1 DPI also (Table 3). Various other receptors like
Msr1, Fas, Selp, Traf1, Treml4 and Pik3ap1 also showed
significant up regulation at 5 DPI.
Differential expression of genes in brain after JEV
infection
Members of a large subset of genes involved in immune
response and inflammation were differentially expressed
in brain of JEV-infected animals. Within this group of
immune response, expression of Oligoadenylate synthe-
tase family members were significantly upregulated dur-
ing the disease course except Oas3 which showed
gradual increase in its expression from 1 to 5 DPI. The
genes belonging to GTPase family also showed very
high level of expression during the disease course. Other
genes involved in immune response which were up
regulated in all time point of infection were Mpa 21,
Mx2, Mx1 Phf11, Tgtp, B2 m and Tap1 (Table S1,
Additional file 2). The inflammatory response genes
include a large number of CXC/CC chemokines family
genes (Table S2, Additional file 3). Cxcl10, Ccl12, Cxcl9,
Cxcl11, Cxcl13 and Tnf-a showed up regulation at 1
DPI with decline at 2 DPI and further up regulation up
to 5 DPI. Ptx3, Ccl3, Spp1, Ccl9, Mefv and Ccl8 showed
significant up-regulation at 5 DPI only. The inflamma-
tory genes like Il1b and Il1a showed up regulation from
4 DPI onwards while Il6 was significantly up regulated
at 5 DPI only. Other important cluster of genes, which
are involved in defense response (Table S3, Additional
file 4), anti-viral response of IFN pathway (Table S4,
Additional file 5) and genes involved in proteolysis
(Table S5, Additional file 6), also showed significant reg-
ulation of expression at early or acute phase of disease.
The genes, which showed significant down-regulation
during the disease course, are involved in cell cycle,
endocytosis, leukotriene metabolic response, signal
transduction, transcription, cell adhesion and apoptosis
(Table 4).
Validation of microarray data by real-time qRT-PCR
analysis
To validate the differential gene expression profiles
obtained by microarray analysis, expression of various
receptors involved in immune response (Clec7a, Masp2),
inflammatory response (Tlr2, Siglec1, Tlr7, and Ifnb1),
signal transduction (Ccrl2), cell adhesion (Icam1) and
d e f e n s er e s p o n s e( T l r 3 )w e r ee x a m i n e db yq R T - P C R .
These genes were chosen on the basis of their signifi-
cant regulation at early phase of infection or at disease
severity phase. The data demonstrate that the overall
results of qRT-PCR were consistent with those of the
microarray analysis. Although several fold differences
was observed between these two types of analysis
because of intrinsic differences between the techniques,
the RT-PCR results reveal the same relative regulation
of transcription as the microarray data, and confirm that
expression of the selected genes was significantly
increased in response to infection with JEV (Figure 4).
174 168 213
340 44 215
(A) 
110 232 227
262 122 303
(B) 
610 (C)  223 119
65 414 319
Figure 3 Comparison of gene expression at different days of
infection. A Venn diagram depicting the differentially expressed
genes (≥2.0-fold change or ≤ -2.0-fold change; P ≤ 0.05) unique or
common at (A) 1 DPI versus 2 DPI (B) 1 DPI versus 4 DPI and (C) 1
DPI versus 5 DPI. Left circle corresponds to the 1 DPI while right
circle in each figure corresponds to 2, 4 and 5 DPI respectively.
Green and red indicates down regulated and up regulated genes
respectively.
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The clinical outcome of a viral infection is largely
dependent on the balance between host response and
viral replication rates. The interaction of the virus with
cell and evasion of the host immune response is crucial
to the development of disease in a susceptible host.
Japanese encephalitis (JE) is, at present, the single most
important cause of viral encephalitis in Asia. In addition
to causing acute illness with a high mortality rate, the
disease may leave survivors with major mental and phy-
sical disabilities. Despite the fact that Japanese encepha-
litis is a major disease affecting the tropical world, little
is known of its pathogenesis due, partly, to the lack of a
suitable animal model and the complex cell interactions
in infected individuals. Understanding the events that
occur within the central nervous system after viral expo-
sure is necessary if effective therapeutic interventions
against viral encephalitis are to be developed.
The current investigation shows global transcription
profile in the brain of JEV-infected animal in a natural
route of exposure. In this study, after subcutaneous
infection, animals started showing JE specific symptoms
from 3-day post-infection. The tremendous increase in
viral load was observed from 4 DPI in this animal
model, which may be because of the completion of virus
dissemination and release from brain cells. In addition
to this, another mechanism behind this robust increase
in viral load may be the increase in viral spread through
a haematogenous route via endothelium [9], because at
this time point of infection there was an increase in
BBB permeability also. However, the detailed study is
required to explore the possible mechanism of JEV
entry in to the CNS. The greatest difference in the gene
expression was observed when the viral load peaked in
the brain. However, viral titre remains constant after 5
day until time to death; this confirms the role of host
response in the severity of disease rather than virus
itself. As reported earlier the pooled RNA samples were
used for microarray analysis to reduce the effects of bio-
logical variation and to easily find the substantive differ-
ences [11]. Genes that were differentially expressed
during infection can potentially provide insights into the
complex regulatory phenomena in response to JEV
infection.
The global transcription profile of the mouse brain
infected with JEV revealed the activation of a variety of
antiviral host defenses early after infection: activation of
innate immune responses, protein processing, interfer-
ons and interferon-stimulated genes, complement sys-
tem, activation of natural killer cells, macrophages and
leukocyte infiltration into brain. These indicated the
induction of an important local inflammatory response
by the host after the infection of CNS. The major set of
genes/pathways with increased expression observed in
present study with JEV are similar to those reported for
other neuroinvasive viruses like West Nile virus (WNV).
These results suggest that some pathways are commonly
activated during neurotropic viral infection of the CNS,
and the gene products like Ifn-g,C x c l 1 0 / I P - 1 0e t c .
involved in protective roles at early phase of infection
may also contribute to the pathogenesis of the disease at
later stage [2,12].
In Flaviviral encephalitis both macrophage and T-cell
infiltration appear to play an important role in the virus
entry to CNS [13]. The extravasations of these inflam-
matory cells and generation of host response may
require the activation of different mediators involving,
respectively, selectins and their ligands, chemokines and
chemokine receptors, proinflammatory cytokines, integ-
rins and cell adhesion molecules (CAMs) and matrix
metalloproteinases (MMPs).
Chemokines are now recognized as critical regulators
of leukocyte trafficking into the CNS. Numerous studies
have revealed that resident cell populations of the CNS
are able to synthesize and secrete a variety of chemo-
kines. Astrocytes and microglia are the primary source
of chemokines following infection with a wide range of
neurotropic viruses. Neurons are also capable of secret-
ing chemokines during JEV and WNV infection [7,14].
Table 2 Representation of statistically significant genes
categorised into genetic pathways by the KEGG
classification system, in mouse brain after JEV infection
KEGG Pathway Number of
genes
P-value
Intracellular signaling cascade 192 1.4E-05
Negative regulation of biological process 187 0.0002
Immune response 136 1.7E-25
Cell adhesion 132 1.03E-05
Defense response 106 1.2E-09
Apoptosis 77 0.001
Inflammatory response 44 1.8E-05
Chemotaxis 39 6.2E-08
Antigen processing and presentation 39 4.3E-16
Integrin-mediated signaling pathway 26 0.0008
G-protein-coupled receptor binding 19 0.0001
Interleukin binding 18 2.1E-05
Response to virus 18 3.1E-05
Cytokine and chemokine mediated
signaling pathway
17 0.0001
Chemokine activity 16 3.3E-05
Chemokine receptor binding 16 3.3E-05
Complement activation 14 0.0003
Leukocyte mediated immunity 11 0.0005
MHC protein complex 10 1.6E-08
Immunoglobulin mediated immune
response
10 0.0004
Leukocyte chemotaxis 10 0.001
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Page 5 of 13Table 3 Differential expression of cell surface molecules in brain after JEV infection
Biological Process Gene
Symbol
Accession No Description Fold change over mock-
infected
1
DPI
2
DPI
4
DPI
5
DPI
Immune response Clec7a† NM_020008 C-type lectin domain family 7 0.49 2.34 1.32 6.34
Immune response Clec5a NM_001038604 C-type lectin domain family 5 1.32 1.85 2.07 5.90
Protein binding scavenger Lgals3bp NM_011150 Lectin, galactoside-binding, soluble, 3 binding
protein
4.23 3.58 3.92 4.90
Inflammatory response Tlr2† NM_011905 Toll-like receptor 2 0.87 1.34 1.40 4.90
Cell adhesion Sell NM_011346 Selectin, lymphocyte -0.96 -0.55 -0.60 4.85
Inflammatory response Siglec1† NM_011426 Sialic acid binding Ig-like lectin 1 2.39 2.80 2.29 4.83
Immune response Clec4e NM_019948 C-type lectin domain family 4 -0.87 -0.46 -0.61 4.57
Signal transduction Gpr84 NM_030720 G protein-coupled receptor 84 2.10 2.66 3.25 4.47
Endocytosis Msr1 NM_031195 Macrophage scavenger receptor 1 -0.94 -0.56 1.10 4.40
Defense response Tlr3† NM_126166 Toll-like receptor 3 3.56 2.47 5.03 4.27
T cell mediated cytotoxicity Ptprc NM_011210 Protein tyrosine phosphatase, receptor 1.63 1.78 2.00 4.27
Signal transduction Ccrl2† NM_017466 Chemokine (C-C motif) receptor-like 2 1.66 2.50 1.98 4.16
Cytokine & Chemokine signaling Lilrb3 NM_011095 Leukocyte immunoglobulin-like receptor 2.06 1.94 0.65 4.09
Immune response Lgals3 NM_010705 Lectin, galactose binding, soluble 3 1.58 1.40 1.40 4.00
Defense response Tlr1 NM_030682 Toll-like receptor 1 2.38 2.15 2.34 3.92
Apoptosis Fas NM_007987 Fas (TNF receptor superfamily) 0.24 0.79 0.77 3.90
Antibody-dependent cellular
cytotoxicity
Fcgr1 BC025535 Fc receptor, IgG, high affinity I 4.23 1.72 3.05 3.79
Immune response Masp2† NM_010767 Mannan-binding lectin serine peptidase 1.66 2.74 3.70 3.75
ADP-ribosylation Plec1 BC024074 Plectin 1 2.35 1.15 2.57 3.71
Inflammatory response Tlr4 NM_021297 Toll-like receptor 4 2.11 1.96 2.15 3.57
Cytokine & Chemokine signaling Csf2rb2 NM_007781 Colony stimulating factor 2 receptor 1.10 1.08 1.38 3.57
Inflammatory response Selp NM_011347 Selectin, platelet -0.06 0.54 -0.67 3.57
Cell adhesion Icam1† BC008626 Intercellular adhesion molecule 0.85 0.85 0.82 3.57
NC Lgals9 NM_010708 Lectin, galactose binding, soluble 9 2.27 1.18 2.41 3.54
Cytokine & Chemokine signaling Csf2rb1 AK154286 Colony stimulating factor 2 receptor 0.57 1.23 1.43 3.52
Immune response Il18bp NM_010531 Interleukin 18 binding protein 2.59 0.90 1.72 3.32
NC Fcgr4 NM_144559 Fc fragment of IgG, low affinity IIIa, receptor 2.06 1.17 3.39 3.31
Inflammatory response Tlr7† NM_133211 Toll-like receptor 7 0.52 0.97 1.80 3.26
Cell adhesion Amica1 NM_001005421 Adhesion molecule, interacts with CXADR antigen
1
1.08 0.78 0.72 3.24
Immune response Cd8a NM_001081110 CD8 antigen, alpha chain -0.97 -0.55 -0.60 3.15
Cell adhesion Vcam1 NM_011693 Vascular cell adhesion molecule 1 1.06 0.54 0.83 3.13
Phagocytosis Fcgr2b NM_010187 Fc receptor, IgG, low affinity IIb 0.19 0.65 0.17 3.09
Signal transduction Osmr NM_011019 Oncostatin M receptor 0.52 0.36 1.19 2.86
NC Il21r NM_021887 Interleukin 21 receptor 1.63 1.21 1.04 2.85
Defense response Cd180 NM_008533 Lymphocyte antigen 78 -1.40 1.32 2.41 2.85
Defense response Clec2d NM_053109 C-type lectin domain family 2 2.14 0.97 2.40 2.83
NC Lair1 NM_178611 Leukocyte-associated Ig-like receptor 1.01 1.48 1.27 2.80
Type IIa hypersensitivity Fcer1g NM_010185 Fc receptor, IgE, high affinity I, gamma
polypeptide
0.98 1.21 0.81 2.78
Signal transduction Admr NM_007412 Adrenomedullin receptor 1.38 0.61 0.84 2.71
Cell adhesion Itgb2 NM_008404 Integrin beta 2 0.60 1.11 0.58 2.68
Signal transduction Pilra NM_153510 Paired immunoglobin-like type 2 1.20 2.17 1.38 2.64
Apoptosis Traf1 NM_009421 Tnf receptor-associated factor 1 1.12 0.64 0.62 2.62
Signal transduction Il15ra NM_008358 Interleukin 15 receptor, alpha chain 1.29 0.77 1.52 2.60
Inflammatory response Edg3 NM_010101 Sphingolipid g-protein-coupled receptor, 1.66 1.63 1.71 2.57
Signal transduction Il10ra NM_008348 Interleukin 10 receptor, alpha 0.72 1.06 0.89 2.55
NC Paqr5 NM_028748 Progestin and adipoq receptor family member V 1.24 1.49 2.51 2.47
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cell activation chemokines, such as Cxcl10/IP-10,
Cxcl11/I-TAC, and Cxcl9/Mig-1 suggests their role in
the infiltration of leucocytes at an early phase of host
response to highly neuroinvasive JEV infection. These
chemokines were also up regulated in the brain of ani-
mals infected with highly neuroinvasive strains of WNV
[12]. Various reports suggest that the interferon and
interferon-regulated genes are playing important role in
the activation of leukocytes and their infiltration to
Table 3 Differential expression of cell surface molecules in brain after JEV infection (Continued)
NC Treml4 NM_172623 Triggering receptor expressed on myeloid cells-like
4
0.33 0.83 -0.69 2.45
Cell adhesion Itgam NM_008401 Integrin alpha M 0.66 0.71 1.60 2.44
Proteolysis Arts1 NM_030711 Type 1 TNF receptor shedding aminopeptidase
regulator
1.36 0.98 1.50 2.40
Signal transduction Pik3ap1 NM_031376 Phosphoinositide-3-kinase adaptor protein 1 0.96 1.25 1.23 2.37
Inflammatory response Tnfrsf1b NM_011610 Tumor necrosis factor receptor superfamily,
member 1b
0.56 0.47 0.39 2.31
Signal transduction Il12rb1 NM_008353 Interleukin 12 receptor, beta 1 1.06 0.57 0.35 2.25
Chemotaxis Ccr5 NM_009917 Chemokine (C-C motif) receptor 5 1.18 1.66 1.40 2.22
NC Il2rg NM_013563 Interleukin 2 receptor, gamma chain 1.28 0.43 -0.28 2.19
Inflammatory response Cd14 NM_009841 Cd14 antigen 0.15 0.78 0.14 2.12
Proteolysis Lnpep NM_172827 Leucyl/cystinyl aminopeptidase 0.78 1.01 0.67 2.10
Immune response Cd40 NM_170701 CD40 antigen 0.67 0.24 0.35 2.10
Cytokine & Chemokine signaling Il2rb NM_008368 Interleukin 2 receptor, beta chain 0.17 0.63 0.09 2.10
† Gene regulation was validated by Real time qRT-PCR.
Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
NC Not classified.
Table 4 Down regulated genes expressed in brain after JEV infection
Biological process Gene Symbol Accession No Description Fold change over mock-infected
1 DPI 2 DPI 4 DPI 5 DPI
Defense response H2-Q1 U96752 Major histocompability complex Q1b -1.56 -2.45 -4.46 -4.35
Endopeptidase
Inhibitor
Pbp2 NM_029595 Phosphatidylethanolamine binding protein 2 -2.67 -4.40 -1.91 -4.28
Cell cycle Bmpr2 NM_007561 Bone morphogenic protein receptor -3.94 -4.10 -3.91 -4.02
Oxidative stress Epx NM_007946 Eosinophil peroxidase -1.05 1.05 -1.81 -3.75
Vasoconstriction Avp NM_009732 Arginine vasopressin -3.09 3.04 -2.71 -3.57
T cell mediated cytotoxicity Ptprc AK088215 Protein tyrosine phosphatase, receptor type, C -0.58 -0.55 -0.62 -3.35
Inflammatory response Ccl24 NM_019577 Chemokine (C-C motif) ligand 24 -1.83 0.39 -0.08 -3.13
Leukotriene metabolic process Ltc4 NM_008521 Mus musculus leukotriene C4 synthase -0.30 0.37 -0.10 -3.01
Transcription Rorb AK044421 RAR-related orphan receptor beta 0.88 0.91 0.83 -2.91
Endocytosis Mrc1 NM_008625 Mannose receptor, C type 1 -1.34 -0.42 -1.41 -2.81
Signal transduction Calcr NM_007588 Calcitonin receptor -3.72 0.03 -2.71 -2.80
Leukotriene metabolic process Alox12 NM_007440 Arachidonate 12-lipoxygenase -0.73 0.35 -0.10 -2.72
NC Msr2 NM_030707 Macrophage scavenger receptor 2 0.29 0.33 0.44 -2.59
Transport Trpa1 NM_177781 Transient receptor potential cation channel 0.11 -2.00 -0.19 -2.52
Microtubule-based process Kif1b NM_207682 Kinesin family member 1B -0.92 -1.69 -2.30 -2.48
Immune response Cxcl4 NM_019932 Chemokine (C-X-C motif) ligand 4 -0.61 0.06 -0.52 -2.33
Translation Eif2s3x NM_012010 Eukaryotic translation initiation factor -0.28 -2.47 -2.29 -2.27
Transcription Zfp101 NM_009542 Zinc finger protein 101 -0.48 -0.36 -2.10 -2.20
Transcription Irx6 NM_022428 Iroquois related homeobox 6 -1.12 -0.58 -1.20 -2.19
Prostaglandin biosynthesis Ptgis NM_008968 Prostaglandin I2 -0.67 -0.46 -1.19 -2.19
MAPK activity Prok2 NM_015768 Prokineticin 2 -1.67 -0.53 -1.76 -2.13
Cell adhesion Pcdh12 NM_017378 Protocadherin 12 -0.17 -0.27 -0.68 -2.10
Apoptosis Ngfr NM_033217 Nerve growth factor receptor -1.74 0.32 -1.73 -2.00
NC Not classified.
Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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Page 7 of 13CNS. In this study, the earliest consistent transcriptional
response was an increase in transcript cluster of Ifn-
associated genes. This cluster includes Ifn-a,I f n - b,a n d
Ifn-g regulated genes. These genes were also found to
be involved in the pathogenesis of West Nile virus ence-
phalitis [15,16].
Interestingly, chemokines which are responsible for
infiltration of monocytes and macrophage like Ccl5/
RANTES and Ccl4/MIP-1b showed increased expression
at an acute phase of infection and increases the infiltra-
tion of monocyte and macrophages. At this phase of
infection before severity of disease, there was an increase
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Figure 4 Validation of Microarray data of selected genes by qReal-Time RT-PCR. The mRNA expression levels of various genes were
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Page 8 of 13in expression of various proinflammatory mediators also
like Tnf-a,I l 1 a,I l 1 b, Il-12 and Ccl2/MIP-1a along with
chemoattractants. These immune mediators may be
exacerbating the infiltration of inflammatory cells by
increasing the expression of various integrins, cell adhe-
sion molecules, selectins and increased blood-brain bar-
rier permeability. A study with neural stem/progenitor
cells infected with JEV also suggested the possible role of
these cytokines in the cellular infiltration [17]. Thus,
according to the present data it can be hypothesized that
the uncontrolled expression of these mediators may be
detrimental leading to the disease severity.
Cell-cell adhesion mediated by various genes is critical
for interaction of lymphocytes and antigen presenting
cells with endothelium and recruitment to the inflam-
mation site. Recent report suggests that Icam1 plays an
important role in WNV neuroinvasion and this is also
involved in the blood-brain barrier permeability and the
progression of neuroinflammation [18-20]. The combi-
nation of IFN-g with TNF-a or IL-1 can strikingly up
regulate the expression of these adhesion molecules [21]
and our results also confirm the similar induction of
these genes. Though adhesion molecules showed impor-
tant role in neuroinflammation, a more thorough under-
standing will help to develop effective anti-inflammation
strategies. The reports also suggested the importance of
integrins in virus entry and a prominent endothelial cell
receptor was also identified as the functional receptor
for WNV and JEV in vertebrate cells [22].
Toll-like receptors signal transduction leads to the
expression of several proteins that have important roles
in the inflammation and immune response to virus.
Recent report suggests that Tlr3 is involved in the
WNV replication in brain and induction of neuronal
injury, may be through inflammation induced cell death
in the brain [23]. The present data also showed the
increased expression of Tlr3 along with TNF-a at an
e a r l yp h a s eo fJ E Vi n f e c t i o na n di tm a yb ei n v o l v e di n
virus entry and resultant encephalitis. Studies showed
that the induction of Tlr2-mediated cytokine response
in the brain contributes to the death of the animal [24].
Tlr2 and Tlr3 cooperation leads to the expression of the
macrophage chemoattractants Ccl2 and Ccl5 [25], which
may be the case in JEV infection also. Other receptors
like Tlr1, Tlr4 and Tlr7 are known to be involved in the
exacerbation of virus-induced inflammation and defense
response [26,27]. The TLR mediated pathway has been
supported with various other important signaling recep-
tors like Lilrb3, Ptprc [28,29]. The transcription profile
of these receptors during disease course suggest a
cumulative effect of these genes in JEV pathogenesis.
T h ei n n a t ei m m u n er e s p o n s eo fm u l t i c e l l u l a ro r g a n -
isms is initiated by the binding of soluble and mem-
brane-bound host molecules including lectins to the
surface of pathogenic organism. These pattern recogni-
tion receptors (PRRs) are required for signal transduc-
tion during host response. Lectin receptors like
dendritic cell receptor Clec7a, Clec4e are playing impor-
tant role in the activation of macrophage and innate
immune response [30,31]. Recent reports suggest the
critical role of macrophage receptor Clec5a in dengue
and Japanese encephalitis severity [8,32]. Other macro-
phage receptors like Masp2 and Siglec1 plays important
role in inflammation [33,34]. Taken together, it can be
hypothesized that, the JEV activates signal transduction
through these receptors, exacerbates the inflammation,
and disease severity. These a r et h en e w l ye x p l o r e dp a t -
tern-recognizing C-type lectin receptors on dendritic
cells and macrophages and targeting these molecules
may provide improved therapeutic options.
The data also presents an interesting set of genes in
JEV pathogenesis. These are the caspases, which are not
only playing an essential role during apoptotic cell
death, but a subfamily of them–the inflammatory cas-
pase, are associated with immune responses to microbial
p a t h o g e n s[ 3 5 ] .T h e s ei n c l u d ec a s p a s e - 1 ,4 ,5 ,1 1a n d
12. Activation of inflammatory caspases, such as cas-
pase-1 and caspase-5, occurs upon assembly of an intra-
cellular complex, designated the inflammasome [36].
The activation of various pattern recognition receptors
like Tlr, C-type lectins and up regulation of Casapse-1,
Caspase-4, Pycard, Cathepsin, Il1b a n dI l 1 8 b pi n d i c a t e s
the possible generation of inflammasomes during JEV
infection. The critical role of Cryopyrin/Nalp3 inflam-
masomes in case of virus infection has already been dis-
cussed [37]. These inflammasomes may be playing
important role in JEV pathogenesis and further research
is required to identify the role of these inflammasomes
in JEV infection.
The present study also provides various important
mediators of host anti-viral response at an early phase of
infection, those with increased expression included Mx1
and Mx2 (myxovirus resistance 1 and 2), antiviral
GTPases, as well as various members of the Oas family,
Guanylate nucleotide binding proteins and TRIM protein
family. Oas has shown involvement in west-nile virus
infection also [38]. Some of these genes like, Oasl2,
Oas1a, Oasl1, G1p2, Ifit3 and Iigp2 showed significant
regulation at an early phase of infection and these results
were consistent with our earlier report on host response
in neuronal cell infected with JEV [7]. The significant
regulation of these genes along with Trim proteins like
Trim 30, 25 and Trim 34 was also observed in the brain
of animals infected with highly neuroinvasive strains of
WNV [12]. The genes of complement system like C1r,
C2, C3, and C4b are known to recognize pathogen-asso-
ciated molecular patterns (PAMPs) and their involve-
ment in WNV infection is also reported recently [39].
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increased expression, including some Ly6 (lymphocyte)
antigens, a group of molecules that are involved in signal
transduction and cell activation [40].
These data illustrate that the activation of various
PRRs, provides a first line of defense by inducing inter-
ferons, proinflammatory cytokines and chemokines
[41,42]. These mediators can promote tissue damage if
not dampened in a timely manner, such as the increased
leukocytic infiltration, which has aggravated the CNS
inflammation and causes fatal encephalomyelitis during
JEV infection. Recent studies also supported this notion
of immunopathogenesis in JEV infection [43,44]. The
role of chemokines can not be ignored in this neuroin-
flammation as they are critical mediators of neuro-
pathology during JEV infection either by attracting
pathogenic inflammatory cells or directly mediating neu-
rotoxicity and cell death. The involvement of this aggra-
vated inflammation in disease severity has already been
studied with other viral diseases [45-47].
Conclusion
In conclusion, there is clear evidence for an immuno-
pathological mechanism in the pathogenesis of Japanese
encephalitis in mice and may be of use in determining a
role for anti-inflammatory agents in the disease manage-
ment. One of the most interesting aspects of our results
is the information on various receptors that may be
involved in the complex interaction between host and
virus. Resident brain cells appeared to be the source of
early immune mediators while infiltrating leukocyte are
playing important role in the severity of the disease.
This will aid further attempts to control the inflamma-
tory conditions during JEV infection. The further eluci-
dation of significantly regulated receptor-ligand
interaction and resulted signal transduction processes
may demonstrate the complexity of the interplay
between the virus and the host, and may open new ways
for therapeutic strategies for diseases which has inflam-
mation as the major cause of disease severity.
Materials and methods
Virus
The JaOArS982 strain of Japanese encephalitis virus was
employed throughout this study. The virus was propa-
g a t e di ns u c k l i n gB A L B / cm i c e .T h eb r a i nt i s s u ew a s
harvested when clinical signs of sickness became appar-
ent. A 10% suspension of the brain tissue was made by
homogenization in the minimum essential medium
(MEM). It was then centrifuged at 10,000 × g to remove
cellular debris and filtered through 0.22 μms t e r i l ef i l -
ters. The mouse brain tissue-derived virus was stored at
-70°C in small aliquots and was used as the source of
virus for all the experiments.
Virus Titration
The infectivity of the virus stock (PFU JEV/ml) was
assessed by a quantitative plaque-forming assay on the
monolayers of porcine stable (PS) kidney cells. Mono-
layers of cells were inoculated with 10-fold dilutions of
virus sample made in MEM containing 1% FBS and
incubated for 1 h at 37°C with occasional shaking. The
inoculum was removed by aspiration and the mono-
layers were further overlaid with 1.25% methylcellulose
containing MEM with 1% FBS. After incubation for 4
days the overlay medium was removed, the cells were
fixed with methanol and stained with 0.5% crystal violet,
and the end-point titre was determined by macroscopic
counting of plaques.
Virus infection
We have adopted a new mice animal model for Japanese
encephalitis virus infection with modification in age and
the route of infection, as reported by us earlier [8].
Briefly, one-week-old BALB/c mice of either sex were
injected subcutaneously with approximately 10
3 PFU (in
50 μl of PBS) of JEV. Control animals received the same
volume of PBS as the experimental group. All experi-
ments were performed according to the protocol
approved by the Institutional Animal Ethics Committee.
Viral load in the CNS of infected mice
Mice were sacrificed each day post-infection (DPI) from
day 1 to day 6 to harvest brain tissue. The animals were
perfused with cold PBS before harvesting the brain tis-
sue. The cerebral cortex of brain tissue was homoge-
nized in the minimum essential medium (MEM). It was
then centrifuged at 10,000 × g and filtered through
0.22 μm sterile filters. Presence and growth kinetics of
virus was confirmed and titrated in the prepared sample
by plaque formation on the monolayers of porcine stable
(PS) kidney cells.
Histopathological Analysis
Mock- and JEV-infected animals were sacrificed after
specific time points. Tissue sample of brain was dissected
o u ta n df i x e di nB o u i n ’s solution. After fixation, small
pieces were processed by automated tissue processor
(Leica TP1020) dehydrated and embedded in paraffin
wax. Multiple sections of 12-μm thickness were prepared
using automatic microtome (Microm HM360) and
stained with hematoxylin and eosin in Leica Autostain-
XL. Microscopic observation was performed on sections
of cerebral cortex under LEICA DMLB microscope and
photographs were taken using Leica DC 500 camera.
Sample Acquisition, RNA Isolation and Quality Control
Brain tissues were collected from mock- and JEV-
infected group of three mice at different days post
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were stored in RNA later (Qiagen, Hilden, Germany) at
-70°C until processed for RNA extraction. Total RNA
was extracted using the Qiagen (GmbH, Hilden)
RNAEasy Mini kit according to the instructions of the
manufacturer. RNA quality and integrity was assessed
using RNA 6000 Nano Lab Chip on the 2100 Bioanaly-
zer (Agilent, Germany) following the manufacturer’s
protocol. RNA samples with RIN (RNA Integrity Num-
ber) ≥ 8 were used in all experiments. Equal concentra-
tion of total RNA from three animals of each mock-
and JEV-infected group were pooled and used for
microarray analysis. Validation of microarray data of
relevant genes was carried out by qRT-PCR with three
biological replicates without pooling of RNA.
Microarrays and Hybridization
Low RNA Input Fluorescent Linear Amplification Kit
(Agilent, Santa Clara, CA) was used for labeling. Briefly,
both first and second strand cDNA were synthesized by
incubating 500 ng of pooled total RNA with 1.2 μlo f
oligo dT-T7 promoter primer in nuclease-free water at
65°C for 10 min followed by incubation with 4.0 μlo f
5× First strand buffer, 2 μlo f0 . 1MD T T ,1μlo f
10 mM dNTP mix, 1 μl of 200 U/μlM M L V - R T ,a n d
0.5 μlo f4 0U / μl RNaseOUT, at 40 °C for 2 h. Immedi-
ately following cDNA synthesis, the reaction mixture
was incubated with 2.4 μl of 10 mM Cyanine-3-CTP or
2.4 μl of 10 mM Cyanine-5-CTP (Perkin-Elmer, Boston,
MA), 20 μl of 4× Transcription buffer, 8 μl of NTP mix-
ture, 6 μl of 0.1 M DTT, 0.5 μlo fR N a s e O U T ,0 . 6μlo f
inorganic pyrophosphatase, 0.8 μlo fT 7R N Ap o l y m e r -
ase, and 15.3 μl of nuclease-free water at 40 °C for 2 h.
Qiagen’s RNeasy mini spin columns were used for puri-
fying amplified cRNA samples. The quantity and specific
activity of cRNA was determined by using NanoDrop
ND-1000 UV-VIS Spectrophotometer version 3.2.1.
Samples with specific activity >8 were used for hybridi-
zation. 825 ng of each Cyanine 3 or Cyanine 5 labeled
cRNA in a volume of 41.8 μlw e r ec o m b i n e dw i t h1 1μl
of 10× Blocking agent and 2.2 μl of 25× Fragmentation
buffer (Agilent), and incubated at 60°C for 30 minutes
in dark. The fragmented cRNA were mixed with 55 μl
of 2× hybridization buffer (Agilent). About 110 μlo ft h e
resulting mixture was applied to the Agilent Whole
Genome Mouse 4 × 44 k Gene Expression Microarray
(AMADID: 14868, Agilent Technologies) and hybridized
in a two-color comparative format at 65°C for 17 h in
an Agilent Microarray Hybridization Chamber (Sure-
Hyb: G2534A) with hybridization oven. After hybridiza-
tion, slides were washed with Agilent Gene expression
wash buffer I for 1 min at room temperature followed
b ya1m i nw a s hw i t hA g i l e n tg e n ee x p r e s s i o nw a s h
buffer II for 37°C. Slides were finally rinsed with
acetonitrile for cleaning up and drying. Hybridized
arrays were scanned at 5 μmr e s o l u t i o no na nA g i l e n t
DNA Microarray Scanner, Model G2565BA. Data
extraction from images was done using Feature Extrac-
tion software of Agilent.
Microarray Data Analysis
Feature extracted data was analyzed using GeneSpring
Gx v 11.0 software from Agilent. Normalization of the
data was done using per spot per chip intensity depen-
dent lowess normalization. Further quality control of
normalized data was done using correlation based con-
dition tree to eliminate experimental error. Genes that
had ≥2 (Up regulated) and ≤-2 (Down regulated) fold
change at 5 DPI were filtered from the data, irrespective
of their regulation at early time points and selected for
further analysis. Differentially regulated genes were clus-
tered using gene tree to identify significant gene expres-
sion patterns. Ontology based biological analysis was
done using Gene Ontology browser in GeneSpring Gx.
Real Time qRT-PCR
The quantitative real-time RT-PCR was carried out to vali-
date the microarray data with three biological replicates
without pooling of RNA, using gene-specific primers from
Quanti Tect primer assay kit (Qiagen Germany). Quanti
Fast one-step RT-PCR kit (Qiagen Germany) was used for
real time PCR and Glyceraldehyde-3-phosphate dehydro-
genase (Gapdh) was used as an endogenous reference
gene [8]. The relative quantification level of expression
was determined using the 2
nd derivative maximum analy-
sis with the determination of the crossing points for each
transcript. Crossing point values for each gene was nor-
malized to the respective crossing point values for the
reference gene Gapdh. Data are presented as normalized
ratios of genes along with standard error using the Roche
Applied Science E-method [48].
Statistical analysis
For microarray, sequential Student’s t test (time point
versus mock) was used to identify genes differentially
expressed (P ≤ 0.05) for each group and the experiment
was repeated once. The quantitative real-time RT-PCR
data was analyzed by one-way ANOVA followed by
Dunnet’s test for comparison between mock- and JEV-
infected groups. The level of significance was set at P ≤
0.05. The data were expressed as mean ± SE of three
animals per group. The real-time RT-PCR experiments
were repeated twice.
Additional material
Additional file 1: Figure S1. Histopathology of the brain of JEV
infected mouse. Hematoxylin/eosin-stained section of cerebral cortex of
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(a) Control mouse brain showing normal arrangement of neurons in
various layers with blood vessels and glial cells (b) Brain section showing
congestion and dilation of blood vessel (thick black arrow) at 1 DPI (c)
Brain section showing moderate dilation of blood vessel (thick black
arrow) at 2 DPI (d) Brain section showing leukocyte infiltration (thin black
arrow) at 4 DPI (e) Brain section showing perivascular cuffing (thick black
arrow) accumulating leukocytes (thin black arrow) and neurodegenration
at 5 DPI (f) Showing enlarged view of perivascular cuffing and leukocyte
transmigration. (Scale bar = 50 μM).
Additional file 2: Table S1. Genes up regulated in mouse brain after
infection with Japanese encephalitis virus, classified as being
involved in immune response. Genes were considered significantly
upregulated or downregulated if the change in their relative expression
levels was ≥ 2 fold or ≤ -2 fold, respectively.
Additional file 3: Table S2. Genes up regulated in mouse brain after
infection with Japanese encephalitis virus, classified as being
involved in inflammation. Genes were considered significantly
upregulated or downregulated if the change in their relative expression
levels was ≥ 2 fold or ≤ -2 fold, respectively.
Additional file 4: Table S3. Genes up regulated in mouse brain after
infection with Japanese encephalitis virus, classified as being
involved in defense response. Genes were considered significantly
upregulated or downregulated if the change in their relative expression
levels was ≥ 2 fold or ≤ -2 fold, respectively.
Additional file 5: Table S4. Genes up regulated in mouse brain after
infection with Japanese encephalitis virus that can be involved in
Interferon response. Genes were considered significantly upregulated
or downregulated if the change in their relative expression levels was ≥
2 fold or ≤ -2 fold, respectively.
Additional file 6: Table S5. Genes up regulated in mouse brain after
infection with Japanese encephalitis virus that can be classified as
being involved in Proteolysis. Genes were considered significantly
upregulated or downregulated if the change in their relative expression
levels was ≥ 2 fold or ≤ -2 fold, respectively.
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